+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neuropathic Pain"

Conventional and Alternative Pain Treatment Market - Product Thumbnail Image

Conventional and Alternative Pain Treatment Market

  • Report
  • November 2024
  • 173 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
Pain Management Drugs - Global Strategic Business Report - Product Thumbnail Image

Pain Management Drugs - Global Strategic Business Report

  • Report
  • March 2025
  • 250 Pages
  • Global
From
Non-opioid Pain Patch - Global Strategic Business Report - Product Thumbnail Image

Non-opioid Pain Patch - Global Strategic Business Report

  • Report
  • March 2025
  • 194 Pages
  • Global
From
Analgesics - Global Strategic Business Report - Product Thumbnail Image

Analgesics - Global Strategic Business Report

  • Report
  • March 2025
  • 578 Pages
  • Global
From
Opioids Market Report 2025 - Product Thumbnail Image

Opioids Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Neuropathic Pain Market Report 2025 - Product Thumbnail Image

Neuropathic Pain Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Chronic Pain Market Report 2025 - Product Thumbnail Image

Chronic Pain Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Loading Indicator

Neuropathic pain is a type of chronic pain caused by damage to the nervous system. It is often described as a burning, tingling, or shooting sensation. Analgesics are medications used to reduce or eliminate pain. Neuropathic pain is often treated with a combination of analgesics, including non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and anticonvulsants. Other treatments may include physical therapy, nerve blocks, and electrical stimulation. The neuropathic pain market is a rapidly growing segment of the analgesics market. It is driven by the increasing prevalence of chronic pain conditions, such as diabetes, cancer, and multiple sclerosis. The market is expected to benefit from the development of novel treatments, such as gene therapy and stem cell therapy. Some companies in the neuropathic pain market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Eli Lilly. Show Less Read more